News for CSL Limited (CSLN.MX)

”“ Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales ”“ ANN ARBOR, Mich., March 03, 2

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, a key revenue driver at $5.85B in 2023.

Billionaire investor Warren Buffett's firm invests in Australian companies CSL, Life360, and WiseTech in a strategic financial move.

The following slide deck was published by CSL Limited in conjunction with their 2025 Q2 earnings call.

CSL Limited (OTCQX:CSLLY) Q2 2025 Results Earnings Conference Call February 10, 2025 7:00 PM ETCompany ParticipantsChris Cooper - Vice President and Head of...

CSL Ltd has reported rises in profit and revenue for the first half of the 2025 fiscal year, with particular growth in its CSL Behring arm

Establishing sepsis diagnostic InfectID™ as the new standard of care

Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.

The Needle-Free Injector Market is growing rapidly along with the escalating requirements of pain-free drug delivery systems, greater needle-phobic...

According to Research by SNS Insider, Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

As per Fortune Business Insights’ report, the immune thrombocytopenia Market share sector attained a worth of USD 2.99 Billion in 2018. Forecasts indicate a promising path, foreseeing a Compound…

Arcturus shares gain as William Blair affirms Outperform rating

As per Fortune Business Insights’ report, the immunoglobulins Market share sector attained a worth of USD 16.24 Billion in 2023. Forecasts indicate a promising path, foreseeing a Compound Annual…

CSL Limited's FY 2024 results were strong, but FY 2025 guidance fell short due to expected underperformance in certain segments. Read why CMXHF stock is a Hold.

CSL Limited (OTCQX:CSLLY) Q4 2024 Results Conference Call August 12, 2024 9:00 PM ETCompany ParticipantsJoy Linton - CFOChris Cooper - Head, IRPaul McKenzie...

As per Fortune Business Insights’ report, the idiopathic inflammatory myopathy treatment Market share sector attained a worth of USD 652.3 million in 2018. Forecasts indicate a promising path ahead…

The Commonwealth Bank of Australia (ASX: CBA) share price might be up 55% over 10 years. But how fast have CBA's profits grown in that time?

iShares MSCI Australia ETF is a low-cost option for targeted exposure to Australian equities with a focus on large and mid-cap companies. Learn more on EWA ETF here.